Canadian Pharmaceuticals & Biotech Potentially Undervalued Companies

High Tide

Market Cap: CA$277.6m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Verano Holdings

Market Cap: CA$519.4m

Operates as a vertically integrated multi-state cannabis operator in the United States.

Decibel Cannabis

Market Cap: CA$54.8m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

Planet 13 Holdings

Market Cap: CA$75.5m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Curaleaf Holdings

Market Cap: CA$2.6b

Produces and distributes cannabis products in the United States and internationally.

MariMed

Market Cap: CA$31.8m

Engages in cultivation, production, and selling of branded cannabis products in the United States and internationally.

Merck

Market Cap: CA$301.3b

Operates as a healthcare company worldwide.

Medexus Pharmaceuticals

Market Cap: CA$92.4m

Operates as a pharmaceutical company in Canada and the United States.

Fennec Pharmaceuticals

Market Cap: CA$287.6m

Operates as a commercial stage biopharmaceutical company in the United States.

Cresco Labs

Market Cap: CA$620.4m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

TerrAscend

Market Cap: CA$307.7m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Bausch Health Companies

Market Cap: CA$2.2b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

Delivra Health Brands

Market Cap: CA$5.8m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.

SOL Global Investments

Market Cap: CA$2.7m

A private equity firm specializing in emerging growth.

Aurora Cannabis

Market Cap: CA$276.2m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Medicure

Market Cap: CA$11.7m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

Novartis

Market Cap: CA$238.8b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Novo Nordisk

Market Cap: CA$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

Ayurcann Holdings

Market Cap: CA$973.5k

Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.

Thermo Fisher Scientific

Market Cap: CA$189.7b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

TILT Holdings

Market Cap: CA$3.9m

Provides various cannabis products and services in the United States, Canada, and internationally.

Gilead Sciences

Market Cap: CA$192.3b

A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.

Trulieve Cannabis

Market Cap: CA$1.5b

Operates as a cannabis retailer.

Tilray Brands

Market Cap: CA$875.0m

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

Organigram Global

Market Cap: CA$235.1m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

Pfizer

Market Cap: CA$156.8b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Rubicon Organics

Market Cap: CA$29.9m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Johnson & Johnson

Market Cap: CA$586.7b

Engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.

Roche Holding

Market Cap: CA$287.6b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Auxly Cannabis Group

Market Cap: CA$170.9m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Sanofi

Market Cap: CA$93.8b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Herbal Dispatch

Market Cap: CA$9.9m

Owns and operates cannabis e-commerce platforms in Canada and the United States.

Amgen

Market Cap: CA$198.8b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

SNDL

Market Cap: CA$386.3m

Engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada.

Cipher Pharmaceuticals

Market Cap: CA$368.9m

Operates as a specialty pharmaceutical company in Canada.